The invention discloses a group of diagnosis,
typing and prognostic markers for children Langerhans
cell histocytosis, and belongs to the technical field of
disease diagnosis. In the invention, an overall
metabolic profile of
bone marrow aspirates (BMA) of 34 children LCH patients is analyzed, and the patients are divided into three subtypes: single
system diseases (SS), multi-
system diseases (MS-RO-) without dangerous organ tiredness and multi-
system diseases (MS-RO +) with dangerous organ tiredness. The metabonomics characteristics of children diagnosed as LCH are described, the metabolic characteristics of a multi-system LCH (MS-RO +) group with dangerous organs being tired before and
after treatment are comprehensively researched, and important
metabolic markers for molecular diagnosis,
subtype classification,
treatment evaluation and prognosis are provided for children patients suffering from LCH, especially high-risk LCH.